Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of ASTX660 in Healthy Volunteers
NCT04479800Phase 1Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tolinapant in T-cell lymphoma and solid tumor (3 arms), sponsored by Astex Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 8 more. Started Jul 2020; status: completed.
02
Drugs
tolinapant
03
Conditions
T-cell lymphomasolid tumor
Beyond the preview
Go deeper on NCT04479800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479800.